<<Print>>

The Stroke Association Support Network of Ghana (SASNET-Ghana) has called for the inclusion of the management of blood clot in the treatment t of COVID-19 protocols.

The Association, therefore, called for the provision of heparins, drug for the treatment of blood clots at all health facilities that treat COVID-19 to help reduce fatalities in the management of COVID-19 cases in the country.

This was contained in a press release issued by the association at Koforidua and copied to the Ghana News Agency.

The association explained that emerging research indicates that patients who are hospitalized with COVID-19 cases have a high risk of forming disabling or deadly blood clots, otherwise known as Venous thromboembolism (VTE ) which researchers believe is the major cause of fatalities in the treatment of the disease.

The release explained that VTE is the formation of blood clots in the deep veins in the groin, leg, or arm which gradually moves through the blood circulation system and settles in the lungs due to ill health which turns to cause death.

As a result of this new development, the International Society on Thrombosis and Hemostasis has issued a consensus statement on COVID-19 and VTE, together with 70 national and international clinical representative organizations including Stroke Association Support Network-Ghana (SASNET-Ghana) to the World Health Organization (WHO) for adoption in the treatment of COVID-19 cases.